RUA — Rua Bioscience Income Statement
0.000.00%
Last trade - 00:00
- NZ$12.18m
- NZ$9.84m
- NZ$0.36m
- 55
- 13
- 22
- 21
2019 June 30th | R2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0.024 | 0.358 |
Cost of Revenue | |||||
Gross Profit | — | — | — | -0.104 | 0.018 |
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.04 | 3.62 | 6.19 | 7.61 | 6.5 |
Operating Profit | -2.04 | -3.62 | -6.19 | -7.58 | -6.14 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.98 | -3.6 | -6.17 | -7.49 | -5.96 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.97 | -2.81 | -4.42 | -8.64 | -5.96 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.97 | -2.81 | -4.42 | -8.64 | -5.96 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.97 | -2.81 | -4.42 | -8.64 | -5.96 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.014 | -0.02 | -0.035 | -0.06 | -0.039 |